LPP2 mRNA was increased as expected 8 by ~7 fold (P < 0.001) in our combined breast tumor samples and those patients with higher LPP2 expression had a significantly decreased survival rate compared to those with lower LPP2 levels (results not shown). The gene discussed is PLPP2; the disease is breast neoplasm.